查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
乳房再造市场增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1190149

乳房再造市场增长、趋势、COVID-19 影响和预测 (2023-2028)

Breast Reconstruction Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，乳房重建市场预计将以 7.1% 的复合年增长率增长。

COVID-19 大流行对乳房植入物市场产生了短期影响，主要是在大流行的早期阶段。 由于法规和封锁，正在进行和预定的手术被推迟或取消，阻碍了乳房植入物市场的增长。 然而，在美国女性中 COVID-19 大流行期间，人们对外貌的兴趣和意识有所增加，包括隆胸和隆胸。 例如，ASPS 在 2021 年 4 月的一份研究报告中发现，与大流行之前相比，接受调查的女性中有 11% 更倾向于整容或非手术程序。 因此，随着从 COVID-19 大流行的影响中迅速恢復，市场有望增长。

推动所研究市场增长的主要因素是乳腺癌患病率的增加。 根据 GLOBOCAN 2020，乳腺癌已超过肺癌成为世界上诊断最多的癌症。 据世界卫生组织称，2020 年全球约有 230 万女性被诊断出患有乳腺癌。 在过去五年中，大约有 780 万女性被诊断出患有乳腺癌。 亚洲女性的乳腺癌患病率很高，占 2020 年所有女性癌症病例的 22.9%。 人们越来越意识到乳房重建方案的安全性，这让接受乳房切除术和其他乳腺癌手术的女性在选□□择重建过程时更加放心。

创新产品的兴起正在推动市场的增长。 例如，2020 年 10 月，GC Esthetic 推出了一种新型圆形乳房植入物 Perle。 它采用反面技术开发，可减少炎症并更容易放置和切开。 这种先进的乳房植入物的引入有望促进市场增长。

因此，诸如乳腺癌发病率上升、全球人口意识提高以及创新产品推出等因素预计将推动研究市场的增长。 然而，乳房重建的高成本是製约市场增长的主要因素。

乳房再造市场趋势

在预测期内，乳房植入物将占据乳房再造市场的最大份额

乳房植入物在乳房重建手术中的使用在全球市场中占有很大份额，预计在预测期内仍将是乳房重建市场的突出趋势。

全球女性对隆胸和重建手术以增强美感的认识和偏好不断提高，这也是有望推动所研究市场增长的因素之一。. 根据 2020 年国际美容整形外科学会 (ISAPS) 的统计数据，美国大约有 193,073 例乳房植入物，比任何其他整容手术都要多。

该领域的市场参与者不断努力寻求更好、更高效的解决方案，通过新产品发布、合作和併购来延长可用产品的使用寿命，这也将补充乳房植入物领域的增长。 例如，2021 年 5 月，GC Esthetic Co., Ltd. 推出了名为 PERLE 的下一代乳房假体，这是一种光滑的乳房假体，采用了一种名为 BioQ 的独特表面技术。

因此，考虑到上述所有因素，例如全球女性对隆胸和重建的认识和偏好不断提高，以及新产品的推出，研究细分市场将在预测期内实现高速增长。去完成。

北美有望在预测期内主导市场

北美由于乳腺癌发病率高、隆胸手术增多以及医疗基础设施成熟，预计将在预测期内主导所研究的市场。

例如，根据美国骨科医师学会2020年的报告，隆胸将成为2020年美国排名前五的整容手术之一。 该地区乳腺癌患病率上升预计将推动该地区乳房植入物市场的增长。 根据 GLOBOCAN 2020 报告，2020 年美国、加拿大和墨西哥的乳腺癌新发病例数分别为 253,465 例、28,026 例和 29,929 例。 因此，预计在预测期内，北美将在乳房植入物市场占据很大的市场份额。 有益的政府举措和增加的研究伙伴关係预计将推动市场的增长。

预计不断增加的产品批准将有助于该地区的市场增长。 例如，2022 年 3 月，Sientra Inc. 获得加拿大卫生部的批准，可以在加拿大销售其表面光滑、高强度粘性（HSC 和 HSC+）硅胶乳房植入物系列。 乳腺癌患病率的上升和该地区市场参与者的日益关注预计将推动北美乳房再造市场的增长。

乳房再造市场竞争分析

乳房再造市场竞争适中，由几家大型企业组成。 目前主导市场的公司包括 Allergan、Sientra Inc.、Ideal Implant Incorporated、Johnson & Johnson、Establishment Labs SA、POLYTECH Health & Aesthetics GmbH、RTI Surgical Inc.、Groupe Sebbin SAS、Integra LifeSciences、GC Aesthetics。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 乳腺癌发病率增加
    • 技术先进的产品介绍
  • 市场製约因素
    • 乳房再造手术费用高昂
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 乳房植入物
    • 组织扩张器
    • 针状真皮基质
    • 其他产品
  • 最终用户
    • 医院
    • 门诊
    • 其他最终用户
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Allergan PLC
    • Sientra Inc.
    • Ideal Implant Incorporated
    • Johnson & Johnson
    • Establishment Labs SA
    • Polytech Health & Aesthetics GmbH
    • RTI Surgical Inc.
    • Groupe Sebbin SAS
    • Integra LifeSciences
    • GC Aesthetics
    • Sebbin
    • Silimed
    • Laboratories Arion

第7章 市场机会未来动向

简介目录
Product Code: 67873

The breast reconstruction market is projected to register a CAGR of 7.1% over the forecast period.

The COVID-19 pandemic had a short-term impact on the breast implant market, primarily during the initial phase of the pandemic. Due to restrictions and lockdown, the ongoing and scheduled surgical procedures were delayed or canceled, hindering the growth of the breast implant market. However, the interest and growing awareness regarding physical appearance increased during the COVID-19 pandemic among women in United States, including breast implants and augmentation. For instance, according to the April 2021 survey report by the ASPS, 11% of the surveyed women were more inclined toward cosmetic surgery or non-surgical procedures than before the pandemic. Therefore, the market is expected to recover soon from the impact of the COVID-19 pandemic and is expected to grow.

The major factor driving the growth of the market studied is the increasing incidence of breast cancer. According to GLOBOCAN 2020, breast cancer surpassed lung cancer and became the most diagnosed cancer worldwide. According to the WHO, in 2020, around 2.3 million women were diagnosed with breast cancer globally. About 7.8 million women have been diagnosed with breast cancer over the last five years. In Asian women, breast cancer prevalence was high, accounting for 22.9% of the total cancer cases in women in 2020. Increasing awareness about the safety of breast reconstruction options is reassuring women undergoing mastectomy and other breast cancer surgeries to choose the reconstruction process.

The increasing products of innovative products are boosting the market's growth. For instance, in October 2020, GC Aesthetics launched Perle, a novel round breast implant. It is developed with reverse surface technology allowing for reduced inflammation and easier placement and incision. Such introduction of advanced breast implants is expected to contribute to the growth of the market.

Thus, factors such as the increasing incidence of breast cancer, increasing awareness among the global population, and innovative product launches are expected to drive the growth of the market studied. However, the high cost of breast reconstruction procedures is the major factor restraining the growth of the market.

Breast Reconstruction Market Trends

Breast Implants Holds the Largest Share in the Breast Reconstruction Market Over the Forecast Period

The usage of breast implants in breast reconstruction surgeries accounted for a significant share of the global market, and this is expected to remain a prominent trend in the breast reconstruction market in the forecast period.

Increasing awareness and inclination among women across the world toward breast augmentation and reconstruction procedures for beauty enhancement is another factor expected to boost the growth of the market studied. According to the 2020 International Society for Aesthetic Plastic Surgeons (ISAPS) statistics, there were about 193,073 breast augmentation procedures in United States in 2020, which was more than any other performed aesthetic surgery.

The market players in the area are continuously working toward better and more efficient solutions and evolving the life of available products through new product launches, collaborations, and mergers and acquisitions, which will also complement the growth of the breast implant segment. For instance, in May 2021, GC Aesthetics Inc. launched a next-generation breast implant called PERLE, a smooth breast implant with a proprietary surface technology called BioQ.

Thus, considering all the above-mentioned factors, such as increasing awareness and inclination among women worldwide toward breast augmentation and reconstruction procedures and new product launches, the segment studied is expected to witness high growth over the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to dominate the market studied during the forecast period due to the high incidence of breast cancer, increasing breast augmentation procedures, and established healthcare infrastructure.

For instance, according to the 2020 report of the American Society of Plastic Surgeons, breast augmentation was one of the top five cosmetic surgical procedures in 2020 in United States. The increasing prevalence of breast cancer in this region is anticipated to boost the growth of the breast implant market in the region. According to the GLOBOCAN 2020 report, the new breast cancer cases in United States, Canada, and Mexico were 253,465, 28,026, and 29,929, respectively, in 2020. Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period. Beneficial government initiatives and increased research partnerships are expected to drive the market's growth.

The rising product approvals are expected to contribute to the growth of the market in this region. For instance, in March 2022, Sientra Inc. received approval from Health Canada to market the company's line of smooth surface, High-Strength Cohesive (HSC and HSC+) silicone gel breast implants in Canada. The rising prevalence of breast cancer and the increasing focus of market players in this region are expected to boost the growth of the breast reconstruction market in North America.

Breast Reconstruction Market Competitive Analysis

The breast reconstruction market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Allergan, Sientra Inc., Ideal Implant Incorporated, Johnson & Johnson, Establishment Labs SA, POLYTECH Health & Aesthetics GmbH, RTI Surgical Inc., Groupe Sebbin SAS, Integra LifeSciences, GC Aesthetics.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Breast Cancer
    • 4.2.2 Introduction of Technologically Advanced Products
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Breast Reconstruction Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Breast Implants
    • 5.1.2 Tissue Expanders
    • 5.1.3 Acellular Dermal Matrices
    • 5.1.4 Other Products
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Care Centers
    • 5.2.3 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan PLC
    • 6.1.2 Sientra Inc.
    • 6.1.3 Ideal Implant Incorporated
    • 6.1.4 Johnson & Johnson
    • 6.1.5 Establishment Labs SA
    • 6.1.6 Polytech Health & Aesthetics GmbH
    • 6.1.7 RTI Surgical Inc.
    • 6.1.8 Groupe Sebbin SAS
    • 6.1.9 Integra LifeSciences
    • 6.1.10 GC Aesthetics
    • 6.1.11 Sebbin
    • 6.1.12 Silimed
    • 6.1.13 Laboratories Arion

7 MARKET OPPORTUNITIES AND FUTURE TRENDS